Corporate calendar for Design Therapeutics, Inc. (DSGN): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Design Therapeutics, Inc. is a biopharmaceutical company in the preclinical phase that focuses on creating treatments for genetic conditions stemming from nucleotide repeat expansions. Its current pipeline targets Friedreich's Ataxia (FA), a severe, progressive, monogenic, and autosomal recessive disease. FA primarily impairs mitochondrial function across various organ systems, resulting in neurological, cardiac, and metabolic complications.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $-0.06 | $36M |
| 2026-09-14 | $0.07 | $231M |
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $-0.03 | $2M |
Price
| Price | $12.30 |
| Market Cap | $769M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ALT · ANNX · AURA · DMAC · ENGN · GALT · IMAB
Explore sector: Healthcare · Biotechnology
More sections of DSGN: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks